应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
PDSB PDS Biotechnology Corporation
未开盘 06-29 16:00:00 EDT
0.8991
+0.0106
+1.19%
盘后
0.9100
+0.0109
+1.21%
18:27 EDT
最高
0.9199
最低
0.8600
成交量
25.96万
今开
0.8600
昨收
0.8885
日振幅
6.74%
总市值
5,018万
流通市值
4,637万
总股本
5,582万
成交额
23.35万
换手率
0.50%
流通股本
5,157万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
PDS Biotechnology Corporation公布NCI主导的转移性结直肠癌二期临床试验第一阶段积极中期数据
美股速递 · 04-15
PDS Biotechnology Corporation公布NCI主导的转移性结直肠癌二期临床试验第一阶段积极中期数据
PDS Biotechnology Corporation宣布调整三期Versatile-003试验方案 将无进展生存期纳入中期分析主要终点以支持加速审批
美股速递 · 02-20
PDS Biotechnology Corporation宣布调整三期Versatile-003试验方案 将无进展生存期纳入中期分析主要终点以支持加速审批
Pds Biotechnology Corporation盘中异动 早盘快速跳水5.82%报0.721美元
市场透视 · 02-04
Pds Biotechnology Corporation盘中异动 早盘快速跳水5.82%报0.721美元
加载更多
公司概况
公司名称:
PDS Biotechnology Corporation
所属市场:
NASDAQ
上市日期:
--
主营业务:
PDS Biotechnology Corporation于2009年1月22日根据特拉华州法律成立。该公司是一家临床阶段的生物技术公司,专注于发现,开发和寻求商业化的新颖的以医院为基础的治疗方案,能够改变治疗模式和危及生命的管理。
发行价格:
--
{"stockData":{"symbol":"PDSB","market":"US","secType":"STK","nameCN":"PDS Biotechnology Corporation","latestPrice":0.8991,"timestamp":1782763200000,"preClose":0.8885,"halted":0,"volume":259617,"hourTrading":{"tag":"盘后","latestPrice":0.91,"preClose":0.8991,"latestTime":"18:27 EDT","volume":2516,"amount":2289.4274,"timestamp":1782772045433,"change":0.0109,"changeRate":0.012123,"amplitude":0.012123},"delay":0,"changeRate":0.011930219471018631,"floatShares":51569799,"shares":55815700,"eps":-0.665407,"marketStatus":"未开盘","change":0.0106,"latestTime":"06-29 16:00:00 EDT","open":0.86,"high":0.9199,"low":0.86,"amount":233504,"amplitude":0.067417,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.665407,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1782806400000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1443672000000,"exchange":"NASDAQ","adjPreClose":0.8885,"preHourTrading":{"tag":"盘前","latestPrice":0.9,"preClose":0.8885,"latestTime":"08:19 EDT","volume":7775,"amount":6847.3064375,"timestamp":1782735570537,"change":0.0115,"changeRate":0.012943,"amplitude":0.012606},"postHourTrading":{"tag":"盘后","latestPrice":0.91,"preClose":0.8991,"latestTime":"18:27 EDT","volume":2516,"amount":2289.4274,"timestamp":1782772045433,"change":0.0109,"changeRate":0.012123,"amplitude":0.012123},"volumeRatio":0.557919,"impliedVol":1.0437,"impliedVolPercentile":0.7092},"requestUrl":"/m/hq/s/PDSB","defaultTab":"news","newsList":[{"id":"1116114948","title":"PDS Biotechnology Corporation公布NCI主导的转移性结直肠癌二期临床试验第一阶段积极中期数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1116114948","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1116114948?lang=zh_cn&edition=full","pubTime":"2026-04-15 20:46","pubTimestamp":1776257183,"startTime":"0","endTime":"0","summary":"PDS Biotechnology Corporation宣布,其PDS01ADC在由国家癌症研究所(NCI)主导的转移性结直肠癌(MCRC)二期临床试验第一阶段的中期研究数据已正式发表。此次公布的数据显示积极的临床效果,为后续治疗方案的推进提供了重要依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PDSB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169029304","title":"PDS Biotechnology Corporation宣布调整三期Versatile-003试验方案 将无进展生存期纳入中期分析主要终点以支持加速审批","url":"https://stock-news.laohu8.com/highlight/detail?id=1169029304","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1169029304?lang=zh_cn&edition=full","pubTime":"2026-02-20 21:31","pubTimestamp":1771594294,"startTime":"0","endTime":"0","summary":"PDS Biotechnology Corporation(简称PDS Biotech)近日公布,其已对三期临床试验Versatile-003的研究方案作出重要修订。新版方案将无进展生存期(PFS)设定为中期分析的主要终点指标,这一调整旨在为后续可能的加速审批提供关键数据支撑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PDSB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609970823","title":"Pds Biotechnology Corporation盘中异动 早盘快速跳水5.82%报0.721美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2609970823","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609970823?lang=zh_cn&edition=full","pubTime":"2026-02-04 23:00","pubTimestamp":1770217232,"startTime":"0","endTime":"0","summary":"北京时间2026年02月04日23时00分,Pds Biotechnology Corporation股票出现异动,股价快速下挫5.82%。截至发稿,该股报0.721美元/股,成交量15.6592万股,换手率0.29%,振幅7.93%。Pds Biotechnology Corporation股票所在的生物技术行业中,整体涨幅为0.46%。Pds Biotechnology Corporation公司简介:PDS Biotechnology Corp 是一家临床阶段的生物技术公司,主要在美国从事药物研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204230033a6d35aaa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204230033a6d35aaa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PDSB"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.pdsbiotech.com","stockEarnings":[{"period":"1week","weight":-0.0447},{"period":"1month","weight":-0.1675},{"period":"3month","weight":0.4861},{"period":"6month","weight":0.168},{"period":"1year","weight":-0.3623},{"period":"ytd","weight":0.168}],"compareEarnings":[{"period":"1week","weight":-0.0046},{"period":"1month","weight":-0.0205},{"period":"3month","weight":0.1394},{"period":"6month","weight":0.0866},{"period":"1year","weight":0.2051},{"period":"ytd","weight":0.0866}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"PDS Biotechnology Corporation于2009年1月22日根据特拉华州法律成立。该公司是一家临床阶段的生物技术公司,专注于发现,开发和寻求商业化的新颖的以医院为基础的治疗方案,能够改变治疗模式和危及生命的管理。","yearOnYearQuotes":[{"month":1,"riseRate":0.545455,"avgChangeRate":0.025289},{"month":2,"riseRate":0.454545,"avgChangeRate":-0.061437},{"month":3,"riseRate":0.272727,"avgChangeRate":-0.164348},{"month":4,"riseRate":0.454545,"avgChangeRate":0.079515},{"month":5,"riseRate":0.545455,"avgChangeRate":0.158069},{"month":6,"riseRate":0.454545,"avgChangeRate":0.00118},{"month":7,"riseRate":0.6,"avgChangeRate":0.099662},{"month":8,"riseRate":0.3,"avgChangeRate":-0.011411},{"month":9,"riseRate":0.3,"avgChangeRate":-0.078335},{"month":10,"riseRate":0.3,"avgChangeRate":-0.019658},{"month":11,"riseRate":0.363636,"avgChangeRate":-0.002317},{"month":12,"riseRate":0.272727,"avgChangeRate":-0.051726}],"exchange":"NASDAQ","name":"PDS Biotechnology Corporation","nameEN":"PDS Biotechnology Corporation"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"PDS Biotechnology Corporation(PDSB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供PDS Biotechnology Corporation(PDSB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"PDS Biotechnology Corporation,PDSB,PDS Biotechnology Corporation股票,PDS Biotechnology Corporation股票老虎,PDS Biotechnology Corporation股票老虎国际,PDS Biotechnology Corporation行情,PDS Biotechnology Corporation股票行情,PDS Biotechnology Corporation股价,PDS Biotechnology Corporation股市,PDS Biotechnology Corporation股票价格,PDS Biotechnology Corporation股票交易,PDS Biotechnology Corporation股票购买,PDS Biotechnology Corporation股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"PDS Biotechnology Corporation(PDSB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供PDS Biotechnology Corporation(PDSB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}